Audio Evidence and the Pharmaceutical Sector - Confronting the Audio Challenge
The amount of regulation governing companies in the pharmaceutical sector continues to increase. Indeed between 2009-2012, the global pharmaceutical industry amassed fines of more than $11bn for criminal wrongdoing, including withholding safety data and promoting drugs for use beyond their licensed conditions.Furthermore, pharmaceutical companies are under investigation by regulators in many jurisdictions for alleged bribery and corruption offences.
In addition to this heightened regul...
To continue reading this story get free access
Please note: That all fields marked with an asterisk (*) are required.